×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations
Yahoo Finance
Cardiff Oncology ( NASDAQ:CRDF ) First Quarter 2024 Results Key Financial Results Net loss: US$10.0m (loss narrowed by...
5 hours ago
Cardiff Oncology: Q1 Earnings Snapshot
Houston Chronicle
SAN DIEGO (AP) — SAN DIEGO (AP) — Cardiff Oncology, Inc. (CRDF) on Thursday reported...
1 day ago
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
GlobeNewswire
In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev...
1 day ago
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Cardiff Oncology (CRDF) delivered earnings and revenue surprises of 12% and 86.36%, respectively, for the quarter ended March 2024.
1 day ago
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript
Yahoo Finance
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript May 3, 2024 Cardiff Oncology, Inc. isn't one of the 30 most popular...
1 day ago
Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical ...
PR Newswire
The publication underscores the safety profile of onvansertib when combined with the standard-of-care (SoC) chemotherapy+bevacizumab. The...
3 months ago
Cardiff Oncology Inc (CRDF) (Q1 2024) Earnings Call Transcript Highlights: Strategic Insights and Financial Health
GuruFocus
Cash and Short-term Investments: As of March 31, 2024, totaled $67.2 million.Cash Used in Operating Activities: $7.7 million in Q1 2024.
1 day ago
Cardiff Oncology reports Q1 EPS (22c), consensus (25c) - TipRanks.com
Tipranks
Reports Q1 revenue $205K, consensus $50k.”During the start of 2024, we presented several important new data sets supporting our first-line...
1 day ago
Cardiff Oncology: Why The Bulls Are Winning Right Now (Rating Upgrade) (NASDAQ:CRDF)
Seeking Alpha
Cardiff is developing a drug for colorectal and pancreatic cancer, showing promise and conducting clinical trials for efficacy.
1 month ago
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
WJTV
Management will hold a conference call on Thursday, May 2 at 4:30 p.m. ET/1:30 p.m. PT -. SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE)...
1 week ago